Multiple myeloma is an uncommon form of cancer, and one that may not produce symptoms right away. Because of this, patients with higher risk due to family history, exposure, or other reasons may need more education about it. How can you explain multiple myeloma to your patients?
Researchers assessed the characteristics that most influence parents’ decision regarding allowing their child to participate in a clinical trial.
Researchers sought to identify frailty assessment tools and determine which are effective in patients undergoing hematopoietic stem cell transplantation.
Results of a retrospective cohort study shows the impact of COVID-19 pandemic on screening rates for breast, prostate, and colorectal cancer.
A 3-step program for testing for penicillin allergy in outpatients at a cancer center demonstrated the effectiveness of nurse-led initiatives.
